Search - tctmd.com

Displaying 181 - 200 of 243

Sort: Relevancy | Date

Presentation ACC 2013

One-Year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Presenter: Masahiro Natsuaki

March 09, 2013

News Conference News ACC 2013

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Jason Kahn

March 09, 2013

News Daily News

TROFI Published: No Clear Benefit of Thrombectomy in STEMI Patients Undergoing PCI

L.A. McKeown

February 12, 2013

Presentation TCT 2013

Treatment of bifurcation lesions with a Drug Eluting Stent with biodegradable polymer.

Presenter: Fazilatum Nesa Malik, Antonio Serra, Nick West, Werner Scholtz, Farzin FATH-ORDOUBADHI, Teguh Santoso, Peep Laanmets, Werner Jung, Fraser WITHEROW, Stefan HOFFMANN, Mohsen Mohandes, Gian Battista Danzi

January 31, 2013

Presentation TCT 2013

SYNERGY Biodegradable Polymer Everolimus Eluting Coronary Stent: Porcine Vascular Compatibility and Polymer Safety Study

Presenter: Gregory Wilson, Angela Marks, Michael Eppihimer, David Knapp, Doug Pennington, Barbara Huibregtse, Keith Dawkins

January 31, 2013

Presentation TCT 2013

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Presenter: Jun-Won Lee, Sung Gyun Ahn, Ji-Hyun Lee, Seung-Hwan Lee, Junghan Yoon, Young-Jin Youn

January 31, 2013

Presentation TCT 2013

NOYA I: A Prospective Randomized Trial of the Biodegradable Polymer NOYA Sirolimus-Eluting Stent Compared with the Durable Polymer FIREBIRD 2 Sirolimus-Eluting Stent in Patients...

Presenter: Bo Xu, Kefei Dou, Yuejin Yang, Shuzheng Lu, Lefeng Wang, Haichang Wang, Zhanquan Li, Lei Wang, YunDai Chen, Yong Huo, Ajay Kirtane, Run-Lin Gao

January 31, 2013

Presentation TCT 2013

Neointimal growth patterns after between biodegradable polymer biolimus-eluting or permanent polymer everolimus-eluting stent implantation assessed with newly developed...

Presenter: Tomohisa Tada, Adnan Kastrati, Robert Byrne, Tibor Schuster, Rezarta Cuni, Lamin King, Salvatore Cassese, Michael Joner, Steffen Massberg, Albert Sch?mig, Julinda Mehilli

January 31, 2013

Presentation TCT 2013

Drug-eluting stent with biodegradable polymer in patients with STEMI – short and long term outcomes: data from e-NOBORI and NOBORI 2 trials

Presenter: Andres I?iguez, Farzin FATH-ORDOUBADHI, Isabel Calvo Cebollero, Albrecht Els?sser, Iskandar Atmowihardjo, Jorge Gaspar, Maciej Lesiak, Kai OPPENL?NDER, Nguyen Quang Ngoc, Ariel Roguin, Nicos Spyrou

January 31, 2013

Presentation TCT 2013

Biodegradable-Polymer Biolimus Eluting Stents Show Better Antiproliferative Efficacy And Vascular Healing Pattern Than Permanent-Polymer Paclitaxel Eluting Stents in a Preclinic...

Presenter: Armando P?rez de Prado, Claudia P?rez-Mart?nez, Alejandro Diego, Jos? Manuel Gonzalo-Orden, Carlos Cuellas, Marta Regueiro, Beatriz Mart?nez-Fern?ndez, Jose M Ajenjo, Maria J Garcia-Iglesias, Felipe Fern?ndez-V?zquez

January 31, 2013

News Daily News

TCTMD’s Top 10 Most Popular News Stories for 2012

Jason Kahn

January 02, 2013

News Conference News TCT 2012

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

November 02, 2012

News Conference News TCT 2012

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

October 24, 2012

Presentation TCT 2012

TCT-6. Biodegradable Polymer-based Biolimus A9-eluting Stent for the Treatment of Infrapopliteal Arteries in Critical Limb Ischemia: Long-term Clinical and Angiographic Follow-up

Presenter: Eugenio Stabile

October 23, 2012

Presentation TCT 2012

TCT-44. LEADERS: 5-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable...

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

TARGET I: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs an Everolimus-Eluting Stent (MicroPort)

Presenter: Run-Lin Gao

October 23, 2012

Presentation TCT 2012

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Presenter: David Kandzari

October 23, 2012

News Conference News TCT 2012

Advertisement

One-Year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

TROFI Published: No Clear Benefit of Thrombectomy in STEMI Patients Undergoing PCI

Treatment of bifurcation lesions with a Drug Eluting Stent with biodegradable polymer.

SYNERGY Biodegradable Polymer Everolimus Eluting Coronary Stent: Porcine Vascular Compatibility and Polymer Safety Study

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

NOYA I: A Prospective Randomized Trial of the Biodegradable Polymer NOYA Sirolimus-Eluting Stent Compared with the Durable Polymer FIREBIRD 2 Sirolimus-Eluting Stent in Patients...

Neointimal growth patterns after between biodegradable polymer biolimus-eluting or permanent polymer everolimus-eluting stent implantation assessed with newly developed...

Drug-eluting stent with biodegradable polymer in patients with STEMI – short and long term outcomes: data from e-NOBORI and NOBORI 2 trials

Biodegradable-Polymer Biolimus Eluting Stents Show Better Antiproliferative Efficacy And Vascular Healing Pattern Than Permanent-Polymer Paclitaxel Eluting Stents in a Preclinic...

TCTMD’s Top 10 Most Popular News Stories for 2012

COMPARE II: Biolimus-Eluting Stent Rivals Everolimus-Eluting Stent in All-Comers Trial

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

TCT-6. Biodegradable Polymer-based Biolimus A9-eluting Stent for the Treatment of Infrapopliteal Arteries in Critical Limb Ischemia: Long-term Clinical and Angiographic Follow-up

TCT-44. LEADERS: 5-Year Follow-up from a Prospective, Randomized Trial of Biolimus A9-eluting Stents with a Biodegradable Polymer vs. Sirolimus-eluting Stents with a Durable...

TARGET I: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs an Everolimus-Eluting Stent (MicroPort)

DESSOLVE II: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs a Zotarolimus-Eluting Stent (Micell)

Several Trials Highlight DES Comparisons

La Trombosis del Stent Causa de casi 1 de cada 10 STEMI

Almost 1 in 10 STEMIs Caused by Stent Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content